Rox Resources (ASX:RXL) Announces A$40 Million Institutional Placement
Rox Resources (ASX:RXL) secures A$40 million through institutional placement to accelerate development of the Youanmi Gold Project.
Tag: Shareholder Updates
Pantoro Gold Limited (ASX:PNR) to Clear Debt After Repayment of Convertible Loan
Pantoro Gold Limited (ASX:PNR) repays its Convertible Loan Facility, becoming debt free ahead of schedule and reducing shareholder dilution.
ONCOSIL MEDICAL LTD (ASX:OSL) Announces Security Consolidation
ONCOSIL MEDICAL LTD (ASX:OSL) announces a 400-to-1 security consolidation, outlining the consolidation ratio, timetable, and impact on securities.
Platinum Asset Management Limited (ASX:PTM) Discusses Potential Merger with L1 Capital
Platinum Asset Management (ASX:PTM) engages in preliminary merger talks with L1 Capital, aiming to create a combined entity managing A$18 billion in funds.
betr Entertainment Limited (ASX:BBT) Completes $114.4 Million Equity Raising
betr Entertainment Limited (ASX:BBT) successfully completes a $114.4 million equity raising, demonstrating strong investor support and endorsing its growth strategy.
Bubs Australia Limited (ASX:BUB) Wins Arbitration Awards
Bubs Australia Limited (ASX:BUB) secures $22.9M and $3.6M arbitration awards against Alpha Group subsidiaries.
Paradigm Biopharmaceuticals Ltd (ASX:PAR) Announces Phase 3 Trial Launch and Financial Update
Paradigm Biopharmaceuticals (ASX:PAR) announces the launch of its Phase 3 trial for knee osteoarthritis and the receipt of a $6.3 million R&D tax refund.
Donaco International Limited (ASX:DNA) Reports Q3 FY2025 Results and Announces Share Acquisition Scheme
Donaco International (ASX:DNA) announces Q3 FY2025 results and a share acquisition Scheme Implementation Deed to strengthen its cash position.
PYC Therapeutics (ASX:PYC) Announces Q1 2025 Shareholder Update
PYC Therapeutics (ASX:PYC) extends cash runway to over $200m and advances polycystic kidney disease program in Q1 2025.
Atomo Diagnostics Limited (ASX:AT1) Completes $3.1M Capital Raise and Board Restructure
Atomo Diagnostics Limited (ASX:AT1) completes a $3.1 million capital raise and announces a board restructure to enhance operational efficiency and drive growth.